Protagenic Therapeutics, Inc. (PTIX) SEC filings
PTIX SEC filings moved a median of +0.01% by the close. PTIX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PTIX overview →
70 measured PTIX SEC filing events.
Where these PTIX SEC filings landedvs 69 measured PTIX SEC filing reactions
| Middle 50% of PTIX SEC filing reactions | -6.82% to +10.60% |
|---|---|
| Median reaction (to close) | +0.01% |
| Measured reactions | 69 |
Point-in-time · zero look-ahead
Half of the 69 PTIX SEC filing events with a measured close landed between -6.82% and +10.60%; 51% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Protagenic Therapeutics, For: Aug 20 | SEC filing · Form 8-K | — | +30.43% | |
| Form 10-Q Protagenic Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +50.04% | |
| Form 10-K Protagenic Therapeutics, For: Mar 31 | SEC filing · Form 10-K | — | +0.00% | |
| Form NT 10-Q Protagenic Therapeutics, For: Jun 30 | SEC filing · Form NT | — | +0.00% | |
| Form NT 10-K Protagenic Therapeutics, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form 8-K Protagenic Therapeutics, For: Mar 31 | SEC filing · Form 8-K | — | -24.22% | |
| Form 10-Q Protagenic Therapeutics, For: Dec 31 | SEC filing · Form 10-Q | +0.00% | -6.53% | |
| Form 8-K Protagenic Therapeutics, For: Feb 03 | SEC filing · Form 8-K | +0.00% | +10.94% | |
| Form 8-K Protagenic Therapeutics, For: Feb 17 | SEC filing · Form 8-K | +0.00% | -7.63% | |
| Form NT 10-Q Protagenic Therapeutics, For: Dec 31 | SEC filing · Form NT | +0.00% | +20.00% | |
| Form 8-K Protagenic Therapeutics, For: Dec 31 | SEC filing · Form 8-K | +0.03% | +76.91% | |
| Form DEF 14A Protagenic Therapeutics, For: Dec 05 | SEC filing · Form DEF | -1.71% | -5.71% | |
| Form 10-Q Protagenic Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +4.19% | +11.52% | |
| Form 8-K Protagenic Therapeutics, For: Nov 20 | SEC filing · Form 8-K | +4.19% | +11.52% | |
| Form NT 10-Q Protagenic Therapeutics, For: Sep 30 | SEC filing · Form NT | +0.00% | -0.48% | |
| Form 8-K Protagenic Therapeutics, For: Nov 03 | SEC filing · Form 8-K | +1.90% | -2.84% | |
| Form 8-K Protagenic Therapeutics, For: Oct 28 | SEC filing · Form 8-K | +2.88% | +7.66% | |
| Form 8-K/A Protagenic Therapeutics, For: May 15 | SEC filing · Form 8-K | — | +6.98% | |
| Form 10-QT Protagenic Therapeutics, For: Jun 30 | SEC filing · Form 10-QT | -1.75% | +16.49% | |
| Form 8-K/A Protagenic Therapeutics, For: May 15 | SEC filing · Form 8-K | -0.51% | -7.79% | |
| Form 8-K Protagenic Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +14.52% | +11.08% | |
| Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance | Press release | +14.52% | +11.08% | |
| Form NT 10-Q Protagenic Therapeutics, For: Jun 30 | SEC filing · Form NT | +0.00% | -6.98% | |
| Form 8-K Protagenic Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -1.08% | +10.43% | |
| Form 8-K Protagenic Therapeutics, For: Jul 18 | SEC filing · Form 8-K | -2.15% | -9.54% | |
| Form 8-K Protagenic Therapeutics, For: Jul 18 | SEC filing · Form 8-K | +0.00% | -1.52% | |
| Form 8-K Protagenic Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +0.00% | -3.44% | |
| Form 8-K Protagenic Therapeutics, For: May 15 | SEC filing · Form 8-K | -2.74% | -11.53% | |
| Form 8-K Protagenic Therapeutics, For: May 20 | SEC filing · Form 8-K | -2.33% | -20.56% | |
| Form 8-K Protagenic Therapeutics, For: May 15 | SEC filing · Form 8-K | -0.68% | +34.22% | |
| Form DEFA14A Protagenic Therapeutics, | SEC filing · Form DEFA14A | -4.37% | -20.92% | |
| Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders | Press release | -0.68% | +34.22% | |
| Form 10-Q Protagenic Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.89% | +2.18% | |
| Form 8-K Protagenic Therapeutics, For: May 02 | SEC filing · Form 8-K | -9.84% | -9.52% | |
| Form 8-K Protagenic Therapeutics, For: Apr 29 | SEC filing · Form 8-K | -3.12% | +5.91% | |
| Form 8-K Protagenic Therapeutics, For: Apr 18 | SEC filing · Form 8-K | +2.10% | -8.73% | |
| Form 10-K Protagenic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -6.20% | |
| Form DEF 14A Protagenic Therapeutics, For: Mar 07 | SEC filing · Form DEF | -1.45% | -10.14% | |
| Form PRE 14A Protagenic Therapeutics, For: Feb 26 | SEC filing · Form PRE | — | +17.11% | |
| Form 8-K Protagenic Therapeutics, For: Feb 21 | SEC filing · Form 8-K | +0.00% | +3.08% | |
| Form 8-K Protagenic Therapeutics, For: Jan 22 | SEC filing · Form 8-K | -1.47% | -6.14% | |
| Form 8-K Protagenic Therapeutics, For: Jan 15 | SEC filing · Form 8-K | — | -2.52% | |
| Form 8-K Protagenic Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -6.69% | -7.69% | |
| Form EFFECT Protagenic Therapeutics, | SEC filing · Form EFFECT | -6.69% | -7.69% | |
| Form S-3/A Protagenic Therapeutics, | SEC filing · Form S-3 | — | +1.62% | |
| Form DEFA14A Protagenic Therapeutics, | SEC filing · Form DEFA14A | -0.56% | -1.37% | |
| Form DEF 14A Protagenic Therapeutics, For: Jan 03 | SEC filing · Form DEF | — | +13.35% | |
| Form EFFECT Protagenic Therapeutics, | SEC filing · Form EFFECT | -5.36% | +2.97% | |
| Form S-1 Protagenic Therapeutics, | SEC filing · Form S-1 | -3.73% | -6.82% | |
| Form PRE 14A Protagenic Therapeutics, For: Dec 18 | SEC filing · Form PRE | +1.76% | +4.96% | |
| Form 8-K Protagenic Therapeutics, For: Nov 29 | SEC filing · Form 8-K | -3.67% | +10.60% | |
| Form 8-K Protagenic Therapeutics, For: Nov 19 | SEC filing · Form 8-K | — | +10.81% | |
| Form 10-Q Protagenic Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -5.58% | |
| Form 8-K Protagenic Therapeutics, For: Nov 04 | SEC filing · Form 8-K | +0.00% | +5.00% | |
| Form 8-K Protagenic Therapeutics, For: Oct 29 | SEC filing · Form 8-K | -9.64% | +2.06% | |
| Form 8-K Protagenic Therapeutics, For: Sep 17 | SEC filing · Form 8-K | +0.00% | -7.97% | |
| Form 10-Q Protagenic Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.14% | +7.33% | |
| Form 8-K Protagenic Therapeutics, For: Jul 24 | SEC filing · Form 8-K | +3.44% | +0.01% | |
| Form S-3 Protagenic Therapeutics, | SEC filing · Form S-3 | +0.00% | -7.77% | |
| Form 8-K Protagenic Therapeutics, For: May 22 | SEC filing · Form 8-K | +0.60% | -7.49% | |
| Form 8-K Protagenic Therapeutics, For: May 22 | SEC filing · Form 8-K | +3.23% | +16.08% | |
| Form 10-Q Protagenic Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | +14.62% | |
| Form 10-K/A Protagenic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.73% | -2.34% | |
| Form 10-K/A Protagenic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +2.38% | |
| Form 10-K Protagenic Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | -1.17% | |
| Form 8-K Protagenic Therapeutics, For: Mar 19 | SEC filing · Form 8-K | — | +5.15% | |
| Form 8-K Protagenic Therapeutics, For: Dec 13 | SEC filing · Form 8-K | — | -11.89% | |
| Form 8-K Protagenic Therapeutics, For: Nov 21 | SEC filing · Form 8-K | +0.68% | +1.35% | |
| Form 10-Q Protagenic Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | — | -1.89% | |
| Form DEF 14A Protagenic Therapeutics, For: Nov 02 | SEC filing · Form DEF | -5.07% | +4.56% |
Keep exploring
More PTIX: earnings → · analyst actions → · PTIX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ZIVO BIOSCIENCE INC (ZIVO) | 122 | 0.00% | 29% |
| American Shared Hospital Services (AMS) | 121 | 0.00% | 48% |
| Xenetic Biosciences, Inc. (XBIO) | 121 | 0.00% | 38% |
| Avenue Therapeutics, Inc. (ATXI) | 120 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.